๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I/II Trial of Adjuvant Dose-Dense Docetaxel/Epirubicin/Cyclophosphamide (TEC) in Stage II and III Breast Cancer

โœ Scribed by Susan Burdette-Radoux; Marie E. Wood; Julie J. Olin; Rebecca S. Laughlin; Abigail M. Crocker; Takamaru Ashikaga; Hyman B. Muss


Book ID
109079511
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
463 KB
Volume
13
Category
Article
ISSN
1075-122X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase I trial of adjuvant chemotherapy w
โœ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w